Form 4 for CSBR CHAMPIONS ONCOLOGY, INC.
Accepted 2024-11-01 00:00:00 ET · period of report 2024-10-31 · accession 0001628280-24-044663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-01 | 2024-10-31 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.63 | +105.1K | 945.5K | +13% | +$276.3K |
| DM | 2024-11-01 | 2024-10-31 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.63 | -105.1K | 0 | -100% | -$276.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-31 | M | A | 16,667 | $5.43 | 962,134 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-31 | M | A | 88,470 | $2.10 | 945,467 | D | — | — | |
| 3 | Derivative | Option to purchase Common Stock | 2024-10-31 | M | D | 88,470 | $2.10 | 0 | D | $2.10 · — to 2024-11-01 | 88,470 Common Stock | (F1) The options were immediately exercisable upon grant on July 19, 2016. |
| 4 | Derivative | Option to purchase Common Stock | 2024-10-31 | M | D | 16,667 | $5.43 | 0 | D | $5.43 · — to 2024-11-03 | 16,667 Common Stock | (F2) 4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on February 4, 2020, May 4, 2020 and August 4, 2020. |